That said, Foundayo is not a magic pill
Because many GLP-1 therapies are prescribed to individuals with obesity or metabolic syndrome, separating medication effects from underlying risk factors can be difficult
I think GLP-1 medications, in general, in some way sensitize cutaneous nerves or nerves of the skin and give people this reaction where they are hypersensitive to stimuli of the skin and causes the sensation in your brain of pain or burning or tingling or itching. Rosen maintained that the symptom can be mitigated by lowering the dosage and then gradually increasing it
Patients with type 2 diabetes who have established diabetic retinopathy at treatment initiation face the highest risk, particularly when experiencing rapid A1c reductions within the first 16 weeks of therapy
Many patients have tried other weight loss programs with little progress, which makes them unsure whether a new program will deliver real results
The data suggest that GLP-1s do not increase the risk of cancer and may even reduce the risk of several types of cancer, particularly in people with obesity or Type 2 diabetes
